טוען...
Targeted Therapies for Multiple Myeloma
Multiple myeloma continues to be a challenging disorder to treat despite improved therapies and the widespread use of proteasome inhibitors and immunomodulatory drugs. Although patient outcomes have improved, the disease continues to invariably relapse, and in the majority of cases, a cure remains e...
שמור ב:
| הוצא לאור ב: | J Pers Med |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8145732/ https://ncbi.nlm.nih.gov/pubmed/33922567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11050334 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|